Ecastolol

This classification denotes a beta-adrenergic blocking agent with the molecular formula C26H33N3O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EEB95DS30P, chemically known as (- )-4-(3-((3,4-dimethoxy-phenethyl)amino)-2-hydroxypropoxy)-3-(5-isoxazolyl)butyranilide. but generally known as ecastolol, which bears US NIH Compound Identifier 208905. European Medicines Agency schedules Ecastolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06444MIG. The term ECASTOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, No. 4, 1987, List 27). ECASTOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ecastolol under HS 29349990 and SITC 51579. As of Q4 2014, ECASTOLOL remains the US FDA Preferred Term for this commodity. Ecastolol bears US NLM identifiers UMLS ID C2348372 and NCI Concept Code C72608. SMILES: O(CC(O)CNCCC1CC(OC)C(OC)CC1)C1C(CC(NC(=O)CCC)CC1)C1ONCC1.